# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA4269058 | F | Antiviral activity against Human coronavirus 229E infected in HEL cells assessed as reduction in virus-induced pathogenicity after 3 days by microscopic method | Human coronavirus 229E | 30 | organism-based format | Scientific Literature | ||
2. | ALA4269059 | A | Cytotoxicity against HEL cells assessed as alteration in cell morphology after 3 days by microscopic method | Homo sapiens | 36 | cell-based format | Scientific Literature | ||
3. | ALA4269060 | F | Antiviral activity against Herpes simplex virus 1 KOS infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect after 3 days by microscopic method | Human alphaherpesvirus 1 | 34 | organism-based format | Scientific Literature | ||
4. | ALA4269061 | F | Antiviral activity against Human herpesvirus 2 strain G infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect after 3 days by microscopic method | Human alphaherpesvirus 2 | 34 | organism-based format | Scientific Literature | ||
5. | ALA4269062 | F | Antiviral activity against acyclovir-resistant TK-defecient Herpes simplex virus 1 KOS infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect after 3 days by microscopic method | Human alphaherpesvirus 1 | 34 | organism-based format | Scientific Literature | ||
6. | ALA4269063 | F | Antiviral activity against Vaccinia virus infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect after 3 days by microscopic method | Vaccinia virus | 34 | organism-based format | Scientific Literature | ||
7. | ALA4269064 | F | Antiviral activity against Human adenovirus 2 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect after 3 days by microscopic method | Human adenovirus 2 | 33 | organism-based format | Scientific Literature | ||
8. | ALA4269065 | T | Selectivity index, ratio of MCC for HEL cells to EC50 for Human coronavirus 229E infected in HEL cells | 30 | cell-based format | Scientific Literature | |||
9. | ALA4269066 | T | Selectivity index, ratio of MCC for HEL cells to EC50 for Herpes simplex virus 1 KOS infected in HEL cells | 30 | cell-based format | Scientific Literature | |||
10. | ALA4269067 | T | Selectivity index, ratio of MCC for HEL cells to EC50 for Herpes simplex virus 2 strain G infected in HEL cells | 30 | cell-based format | Scientific Literature | |||
11. | ALA4269068 | T | Selectivity index, ratio of MCC for HEL cells to EC50 for acyclovir-resistant TK-defecient Herpes simplex virus 1 KOS infected in HEL cells | 30 | cell-based format | Scientific Literature | |||
12. | ALA4269069 | T | Selectivity index, ratio of MCC for HEL cells to EC50 for Vaccinia virus infected in HEL cells | 30 | cell-based format | Scientific Literature | |||
13. | ALA4269070 | T | Selectivity index, ratio of MCC for HEL cells to EC50 for Human adenovirus 2 infected in HEL cells | 30 | cell-based format | Scientific Literature |